CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,757,655 | +18.3% | 148,261 | -18.4% | 0.57% | +12.6% |
| Q3 2022 | $2,332,000 | -2.1% | 181,799 | -46.5% | 0.51% | -12.9% |
| Q2 2022 | $2,383,000 | -21.3% | 339,942 | -7.0% | 0.58% | +3.2% |
| Q1 2022 | $3,029,000 | +87.1% | 365,415 | +52.8% | 0.56% | +112.0% |
| Q4 2021 | $1,619,000 | -36.4% | 239,071 | -52.1% | 0.27% | -57.4% |
| Q1 2019 | $2,544,000 | -17.7% | 498,844 | -36.9% | 0.62% | +12.6% |
| Q4 2017 | $3,092,000 | +1589.6% | 790,872 | +1199.5% | 0.55% | +1810.3% |
| Q3 2015 | $183,000 | -80.8% | 60,858 | -73.7% | 0.03% | -74.1% |
| Q2 2015 | $954,000 | -5.1% | 231,051 | -0.5% | 0.11% | -3.4% |
| Q1 2015 | $1,005,000 | -26.3% | 232,176 | -48.1% | 0.12% | -57.4% |
| Q3 2013 | $1,363,000 | – | 446,957 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
| TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
| SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
| Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
| Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
| Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
| Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
| Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
| FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
| Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |